In summary, using a model of administration of exogenous Sema3E, we confirmed the role of this molecule in host defence against chlamydial infection and revealed the potential of Sema3E treatment to restore the defect of Sema3E deficient individuals in immune protection and to enhance the protection in intact individuals. Here, SEMA3E is linked to chlamydia trachomatis infectious disease.